Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy

NCT00480623 is registered in ClinicalTrials.gov with Agennix as lead sponsor.

NCT NCT00480623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00480623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy
Lead sponsor
Agennix
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2007
Completion date
April 30, 2008
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer